Testing a new virtual reality method for assessing vision in glaucoma patients
A Pilot Study on the Repeatability of a Novel Perimetric Test Administered Via a Virtual Reality Headset.
This study is testing a new virtual reality headset to see if it can make vision tests easier and more comfortable for people with glaucoma compared to the traditional method.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 25 Years to 70 Years |
| Sex | All |
| Sponsor | Envision Health Technologies, Inc. Industry-sponsored |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06549010 on ClinicalTrials.gov |
What this trial studies
This study evaluates a novel head-mounted perimeter using a Virtual Reality (VR) headset as an alternative to the traditional Humphrey Field Analyzer (HFA) for visual field testing in glaucoma patients. Participants will undergo a series of ophthalmic screenings and visual field tests, including both the HFA and the VR headset, to compare the effectiveness and comfort of the two methods. The study aims to gather pilot data that could inform a larger-scale assessment of the VR testing approach. The goal is to improve accessibility and patient experience in glaucoma monitoring.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 25-70 with a diagnosis of primary open-angle glaucoma or healthy subjects without any ophthalmic pathologies.
Not a fit: Patients with significant ocular pathologies or those who have undergone recent eye surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more comfortable and accessible method for glaucoma patients to undergo visual field testing.
How similar studies have performed: While traditional methods like the HFA are well-established, the use of VR for visual field testing is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion / Exclusion Criteria: 1. Age range: 25-70 years 2. For normal subjects: 1. Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects: e.g. retina pathology, glaucoma, cataracts, keratoconus 2. No ocular surgery other than cataract surgery within 6 months prior to the study visit 3. For glaucoma subjects: 1. Patient has a diagnosis of primary open-angle glaucoma 2. Patient is free of any other current or prior ophthalmic pathologies that would potentially cause visual field defects. 3. No other ocular surgery other than glaucoma or cataract surgery within 6 months prior to the study visit 4. No IOP lower than 10 mm/Hg or higher than 30 mm/Hg 4. Refractive Error: 1. Sphere = up to -6.00 D to and up +3.00 2. Cylinder = up to -3.00 is common 5. No past refractive eye surgery 6. No Multifocal or phakic (ICLs) IOL; no multifocal CLs 7. One eligible eye 8. Ability to sit for standard VF bowl exam. Ability to wear VR perimetry headset device.
Where this trial is running
Chicago, Illinois
- Illinois College of Optometry / Illinois Eye Institute — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Michael Chaglasian, OD — Illinois College of Optometry
- Study coordinator: Michael Chaglasian, OD
- Email: mchaglas@ico.edu
- Phone: 312-949-7303
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.